MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study

    N. Bohnen, G. Carli, F. Michalakis, C. Pongmala, M. Emde Boas, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To explore the role of cholinergic dysfunction in dyskinesia symptoms in people with Parkinson’s disease (PD). Background: Dyskinesias, involuntary and sometimes excessive or uncontrolled…
  • 2024 International Congress

    Clinical Profile of Motor Complications in Parkinson’s Disease Patients at A National Tertiary Hospital In Indonesia

    Y. Rapri, A. Jody, A. Tiksnadi, D. Tunjungsari (Depok, Indonesia)

    Objective: To analyse factors associated with motor complications in Parkinson's disease at a national tertiary referral hospital in Indonesia. Background: As Parkinson's disease progresses, levodopa…
  • 2024 International Congress

    Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

    A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)

    Objective: To examine the utility of commercially available skin phosphorylated alpha-synuclein deposition test (pSyn) in patients with clinically ambiguous parkinsonism and its concordance with dopamine…
  • 2024 International Congress

    The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

    S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…
  • 2024 International Congress

    Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder

    A. Falcone, I. Brum, F. Freua, E. Barbosa, R. Cury, J. Parmera (Sao Paulo, Brazil)

    Objective: To describe a stepwise evaluation of a patient with a secondary parkinsonism that mimic idiopathic Parkinson´s Disease (PD). Background: PD clinically established encompasses the…
  • 2024 International Congress

    Eye movements and cognitive function

    A. Ovchynnykova, Y. Trufanov, M. Trishchynska (Kyiv, Ukraine)

    Objective: find out the relationship between eye movements and cognitive function (CF). Background: working in our clinic we have learned to give a pre-assessment of…
  • 2024 International Congress

    Influence of the Level of Education on the Change in Cognitive Function in Parkinson´s Disease. A 5-year Follow-up Study.

    D. Santos García, T. de Deus, C. Cores, M. íñiguez, L. Samaniego, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, I. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, T. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, S. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to know the influence of the level of education (LoE) on the change in cognitive function (CF)…
  • 2024 International Congress

    Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

    G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine periodic and aperiodic EEG correlates of cognition in Parkinson’s disease (PD). Background: Quantitative EEG metrics are increasingly used to describe variations in…
  • 2024 International Congress

    Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations

    O. Bezdicek, R. Biundo, D. Cammisuli, B. Cholerton, J. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, S. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Praha, Czech Republic)

    Objective: To evaluate the psychometric properties of Language, Memory, and Visuospatial Function tests in Parkinson’s Disease (PD) on behalf of the Movement Disorder Society (MDS)…
  • 2024 International Congress

    Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

    N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley